Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
  1. 4 Open-market sale Chief Data Officer sold 4,078 shares at $7.32 ($29,851)
  2. 4 Open-market sale General Counsel sold 4,727 shares at $7.32 ($34,602)
  3. 4 Open-market sale Chief Information Officer sold 4,727 shares at $7.32 ($34,602)
  4. 4 Open-market sale Chief Scientific Officer sold 4,727 shares at $7.32 ($34,602)
  5. 4 Open-market sale Chief Financial Officer sold 7,179 shares at $7.32 ($52,550)
  6. 4 Open-market sale Director sold 96 shares at $7.15 ($686)
  7. 4 Open-market sale Chief Financial Officer sold 5,056 shares at $7.57 ($38,274)
  8. 4 Open-market sale Chief Executive Officer sold 25,085 shares at $7.57 ($189,893)
  9. 4 Open-market sale Director sold 96 shares at $7.16 ($687)
  10. 4 Open-market sale Chief Scientific Officer sold 5,022 shares at $7.42 ($37,263)
  11. 4 Open-market sale Chief Information Officer sold 5,022 shares at $7.42 ($37,263)
  12. 4 Open-market sale Chief Data Officer sold 4,333 shares at $7.42 ($32,151)
  13. 4 Open-market sale Chief Executive Officer sold 12,327 shares at $7.42 ($91,466)
  14. 4 Open-market sale Director sold 101 shares at $7.42 ($749)
  15. 4 Open-market sale General Counsel sold 5,022 shares at $7.42 ($37,263)
  16. 4 Open-market sale Chief Financial Officer sold 6,760 shares at $7.42 ($50,159)
  17. 4 Grant or award Director acquired 7,117 shares (grant or award)
  18. 4 Open-market sale Chief Executive Officer sold 26,867 shares at $8.11 ($217,891)
  19. 4 Open-market sale Chief Financial Officer sold 5,415 shares at $8.11 ($43,916)
  20. 4 Grant or award Director acquired 7,117 shares (grant or award)

Page 9 of 16 · 313 filings